Product Exclusivity Granted by the US Food and Drug Administration

Novack Gary D.

首页> 外文期刊>The ocular surface >Product Exclusivity Granted by the US Food and Drug Administration

【24h】

Product Exclusivity Granted by the US Food and Drug Administration

机译：美国食品药品监督管理局授予的产品专有权

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The ocular surface》 |2016年第1期|共3页
作者
Novack Gary D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Product Exclusivity Granted by the US Food and Drug Administration [J] . Novack Gary D. The ocular surface . 2016,第1期

机译：美国食品药品监督管理局授予的产品专有权
2. Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration [J] . Naci Huseyin, Smalley Katelyn R., Kesselheim Aaron S. JAMA: the Journal of the American Medical Association . 2017,第7期

机译：批准的批准特征和对美国食品和药物管理局批准的药物批准的特点
3. Juries Trump FDA in Writing Drug Labels; FDA Grants Clinical Trial Permission for Human Embryonic Stem Cells; Alerts Issued for Two Biotechnology Products; Japanese Rheumatoid Arthritis Drug Approved in Europe; FDA Criticizes Humira Ad; Amgen's BLA for Bone Drug Accepted; Rules for Claiming Health Benefits from Food and Supplements [J] . Biotechnology Law Report . 2009,第2期

机译：陪审团特朗普FDA撰写药品标签； FDA授予人类胚胎干细胞临床试验许可；两种生物技术产品发出警报；日本在欧洲批准了类风湿关节炎药物； FDA批评Humira广告；接受了安进公司的骨药物BLA；从食品和补品中获取健康益处的规定
4. Food-borne Diseases: Situation of Diarrheal Diseases in Thailand: Food Control Division, Food and Drug Administration, Thailand [C] . anonymous Food and Agriculture Organization of the United Nations/World Hearlth Organization Rgional Conference on Food Safety for Asia and the Pacific . 2004

机译：食品传播疾病：泰国腹泻病的情况：泰国食品管制部，食品和药物管理局
5. Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving US Food and Drug Administration Premarket Approval in 2010 and 2011. [D] . Rathi, Vinay Kumar. 2016

机译：在2010年和2011年获得美国食品药品监督管理局上市前批准的高风险治疗性医疗器械整个产品生命周期中进行的临床研究。
6. Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Generic Drug Products by the US Food and Drug Administration [O] . Barbara M. Davit, Mei-Ling Chen, Dale P. Conner, 2012

机译：美国食品和药物管理局对高度可变的通用药品的参考规模平均生物等效性方法的实施
7. Characteristics of pre-approval and post-approval studies for drugs granted accelerated approval by the US food and drug administration [O] . Naci, Huseyin, Smalley, Katelyn R., Kesselheim, Aaron S. 2017

机译：美国食品和药物管理局加速批准的药品批准前和批准后研究的特征

Product Exclusivity Granted by the US Food and Drug Administration

著录项

相似文献

相关主题

期刊订阅